Correction: CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases (Oncogene, (2007), 26, 19, (2747-2758), 10.1038/sj.onc.1210077);CEACAM1 impedes thyroid cancer growth but promotes invasiveness: A putative mechanism for early metastases

Oncogene

Volumn 26, Issue 19, 2007, Pages 2747-2758

  Liu, W ^a,b   Wei, W ^a,b   Winer, D ^a,b   Bamberger, A M ^c   Bamberger, C ^c   Wagener, C ^c   Ezzat, S ^b,d   Asa, S L ^a,b,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

CEACAM1; Cell adhesion; Metastases; Thyroid cancer; Tumor invasion

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CELL ADHESION MOLECULE; PROTEIN P21; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MORPHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THYROID CANCER; THYROID GLAND; TUMOR VOLUME; XENOGRAFT;

MUS;

EID: 34247545247     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-023-02833-0     Document Type: Erratum

References (50)

1. Bamberger AM, Minas V, Kalantaridou SN, Radde J, Sadeghian H, Loning T et al. (2006). Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation. Am J Pathol 168: 141-150.
2. Bamberger AM, Riethdorf L, Nollau P, Naumann M, Erdmann I, Gotze J et al. (1998). Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 152: 1401-1406.
3. Bamberger AM, Sudahl S, Loning T, Wagener C, Bamberger CM, Drakakis P et al. (2000). The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am J Pathol 156: 1165-1170.
4. Barnett TR, Drake L, Pickle W. (1993). Human biliary glycoprotein gene: characterization of a family of novel alternatively spliced RNAs and their expressed proteins. Mol Cell Biol 13: 1273-1282.
5. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F et al. (1999). Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 252: 243-249.
6. Briese J, Oberndorfer M, Patschenik C, Schulte HM, Makrigiannakis A, Loning T et al. (2005). Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells. J Clin Endocrinol Metab 90: 5407-5413.
7. Brummer J, Neumaier M, Gopfert C, Wagener C. (1995). Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene 11: 1649-1655.
8. Busch C, Hanssen TA, Wagener C, OBrink B. (2002). Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol 33: 290-298.
9. DeLellis RA, Lloyd RV, Heitz PU, Eng C. (2004). Pathology and Genetics of Tumours of Endocrine Organs, WHO Classification of Tumours. IARC Press: Lyons, France.
10. Ebrahimnejad A, Streichert T, Nollau P, Horst AK, Wagener C, Bamberger AM et al. (2004). CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol 165: 1781-1787.
11. Estrera VT, Chen DT, Luo W, Hixson DC, Lin SH. (2001). Signal transduction by the CEACAM1 tumor suppressor. Phosphorylation of serine 503 is required for growth-inhibitory activity. J Biol Chem 276: 15547-15553.
12. Estrera VT, Luo W, Phan D, Earley K, Hixson DC, Lin SH. (1999). The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells. Biochem Biophys Res Commun 263: 797-803.
13. Ezzat S, Zheng L, Kolenda J, Safarian A, Freeman JL, Asa SL. (1996). Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid 6: 409-416.
14. Fagin JA. (1992). Genetic basis of endocrine disease 3. Molecular defects in thyroid gland neoplasia. J Clin Endocrinol Metab 75: 1398-1400.
15. Fournes B, Sadekova S, Turbide C, Letourneau S, Beauchemin N. (2001). The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity. Oncogene 20: 219-230.
16. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. (2001). Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158: 987-996.
17. Hirohashi S, Kanai Y. (2003). Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581.
18. Hsieh JT, Luo W, Song W, Wang Y, Kleinerman DI, Van NT et al. (1995). Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res 55: 190-197.
19. Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N. (1999). cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 18: 5563-5572.
20. Jhiang SM, Sagartz JE, Tong Q, Parker-Thronburg J, Capen CC, Cho JY et al. (1996). Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375-378.
21. Khoo ML, Beasley NJ, Ezzat S, Freeman JL, Asa SL. (2002a). Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab 87: 1814-1818.
22. Khoo ML, Freeman JL, Witterick IJ, Irish JC, Rotstein LE, Gullane PJ et al. (2002b). Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg 128: 253-257.
23. Kinugasa T, Kuroki M, Takeo H, Matsuo Y, Ohshima K, Yamashita Y et al. (1998). Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas. Int J Cancer 76: 148-153.
24. Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT. (1996). Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res 56: 3431-3435.
25. Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T et al. (1995). Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res 55: 1215-1220.
26. Kondo T, Ezzat S, Asa SL. (2006). Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6: 292-306.
27. Kunath T, Ordonez-Garcia C, Turbide C, Beauchemin N. (1995). Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 11: 2375-2382.
28. Leung N, Turbide C, Olson M, Marcus V, Jothy S, Beauchemin N. (2006). Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene 25: 5527-5536.
29. Liu W, Asa SL, Ezzat S. (2005). 1{alpha},25-dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness. Mol Endocrinol 19: 2349-2357.
30. Luo W, Tapolsky M, Earley K, Wood CG, Wilson DR, Logothetis CJ et al. (1999). Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther 6: 313-321.
31. Muenzner P, Rohde M, Kneitz S, Hauck CR. (2005). CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J Cell Biol 170: 825-836.
32. Muller MM, Singer BB, Klaile E, Obrink B, Lucka L. (2005). Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 105: 3925-3934.
33. Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C. (1993). Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA 90: 10744-10748.
34. Obrink B. (1997). CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr Opin Cell Biol 9: 616-626.
35. Ohwada A, Takahashi H, Nagaoka I, Kira S. (1994). Biliary glycoprotein mRNA expression is increased in primary lung cancer, especially in squamous cell carcinoma. Am J Respir Cell Mol Biol 11: 214-220.
36. Oikawa S, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H. (1992). Homotypic and heterotypic Ca(++)-independent cell adhesion activities of biliary glycoprotein, a member of carcinoembryonic antigen family, expressed on CHO cell surface. Biochem Biophys Res Commun 186: 881-887.
37. Olsen A, Teglund S, Nelson D, Gordon L, Copeland A, Georgescu A et al. (1994). Gene organization of the pregnancy-specific glycoprotein region on human chromosome 19: assembly and analysis of a 700-kb cosmid contig spanning the region. Genomics 23: 659-668.
38. Piersanti M, Ezzat S, Asa SL. (2003). Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol 14: 183-191.
39. Pignatelli M, Vessey CJ. (1994). Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 25: 849-856.
40. Plunkett TA, Ellis PA. (2002). CEACAM1: a marker with a difference or more of the same? J Clin Oncol 20: 4273-4275.
41. Powell Jr DJ, Russell J, Nibu K, Li G, Rhee E, Liao M et al. (1998). The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res 58: 5523-5528.
42. Prall F, Nollau P, Neumaier M, Haubeck HD, Drzeniek Z, Helmchen U et al. (1996). CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J Histochem Cytochem 44: 35-41.
43. Riethdorf L, Lisboa BW, Henkel U, Naumann M, Wagener C, Loning T. (1997). Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem 45: 957-963.
44. Ruoslahti E, Obrink B. (1996). Common principles in cell adhesion. Exp Cell Res 227: 1-11.
45. Singer BB, Scheffrahn I, Obrink B. (2000). The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res 60: 1236-1244.
46. Stoffel A, Neumaier M, Gaida FJ, Fenger U, Drzeniek Z, Haubeck HD et al. (1993). Monoclonal, anti-domain and anti-peptide antibodies assign the molecular weight 160 000 granulocyte membrane antigen of the CD66 cluster to a mRNA species encoded by the biliary glycoprotein gene, a member of the carcinoembryonic antigen gene family. J Immunol 150: 4978-4984.
47. Sugg SL, Ezzat S, Rosen IB, Freeman J, Asa SL. (1998). Distinct multiple ret/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83: 4116-4122.
48. Takanishi K, Miyazaki M, Ohtsuka M, Nakajima N. (1997). Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma. Oncology 54: 231-237.
49. Thies A, Moll I, Berger J, Wagener C, Brummer J, Schulze HJ et al. (2002). CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol 20: 2530-2536.
50. Wang L, Lin SH, Wu WG, Kemp BL, Walsh GL, Hong WK et al. (2000). C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Clin Cancer Res 6: 2988-2993.